Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study

DOI Full Paper Access

30

Citations

12

References

2021

Year

Jonathan Kay, Janusz Jaworski, Rafał Wojciechowski, Piotr Wiland, Anna Dudek, Marek Krogulec, Agnieszka Zielińska, Jakub Trefler, Katarzyna Bartnicka-Maslowska, Magdalena Krajewska–Włodarczyk,

Arthritis Research & Therapy

References

	Year	Citations

Page 1